Trade Now

Capital at risk Advertisement
Share Name Share Symbol Market Type Share ISIN Share Description
C4x Discovery Holdings Plc LSE:C4XD London Ordinary Share GB00BQQ2RV18 ORD 1P
  Price Change % Change Share Price Shares Traded Last Trade
  0.00 0.0% 19.025 0.00 09:56:18
Bid Price Offer Price High Price Low Price Open Price
18.40 19.45
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology -5.91 -1.96 48
Last Trade Time Trade Type Trade Size Trade Price Currency
- O 0 19.025 GBX

C4x Discovery (C4XD) Latest News

More C4x Discovery News
C4x Discovery Investors    C4x Discovery Takeover Rumours

C4x Discovery (C4XD) Discussions and Chat

C4x Discovery Forums and Chat

Date Time Title Posts
29/8/202208:30C4X Discovery Holdings plc2,815

Add a New Thread

C4x Discovery (C4XD) Most Recent Trades

No Trades
Trade Time Trade Price Trade Size Trade Value Trade Type
View all C4x Discovery trades in real-time

C4x Discovery (C4XD) Top Chat Posts

Top Posts
Posted at 01/10/2022 09:20 by C4x Discovery Daily Update
C4x Discovery Holdings Plc is listed in the Pharmaceuticals & Biotechnology sector of the London Stock Exchange with ticker C4XD. The last closing price for C4x Discovery was 19.03p.
C4x Discovery Holdings Plc has a 4 week average price of 18.60p and a 12 week average price of 18.60p.
The 1 year high share price is 47.50p while the 1 year low share price is currently 18.60p.
There are currently 252,013,172 shares in issue and the average daily traded volume is 159,214 shares. The market capitalisation of C4x Discovery Holdings Plc is £47,945,505.97.
Posted at 12/8/2022 08:36 by alloa2003
The institutions arent doing the company a favour they are just using the situation to fill their boots ahead of a big deal. This next deal is likely be (potentially) bigger than the last one, so it could be huge. Dont forget these are the institutions that shafted the company a few year ago when they walked into a meeting expecting a fund raising price of 40p+ only to find they were being held to ransom and it was changed to 20p at the last minute. The shares collapsed and there was huge dilution - also the institutions got a load of warrants at 28p as well.
Posted at 11/8/2022 08:07 by alloa2003
I think C4XD is a standout investment in the longer term and will eventually become a cash cow.
Posted at 29/6/2022 11:23 by alloa2003
What is happening here? Looks like the company is slowly dying but behind the scenes negotiations continue on licence deals. I hope funding doesnt become an issue before they sign a deal - looking that way with the share price.
Posted at 28/4/2022 09:16 by alloa2003
You have hit the nail on the head - a point I have mentioned a few times. When people see these huge numbers they think that is it, they dont even see the single digit royalties which are on top of the potential payment figures mentioned. As the C4XD system is basically reformulating and improving existing treatments for oral use, there is little chance of the molecule being rejected at the regulatory stage. Therefore it doesnt take much to see how very quickly this company could turn into a HUGE cash cow, funding not only future funding but, eventually, dividends for shareholders. Yet another untapped and ignored potential gem in my view.
Posted at 27/4/2022 14:24 by alloa2003
Also, the company doesnt seem to be "leaky" when it comes to announcements. I remember the shock fund raising at a 50% discount to the share price. Nobody saw that coming, not even the company - who had previously agreed a much higher price! Final thought. If, as we assume, there is at least one potentially huge deal just around the corner (and other milestones to come), why would the company look to raise funds before the big bounce? Surely if they had to raise funds they would do it in tandem with good news?
Posted at 19/4/2022 07:39 by alloa2003
C4X Discovery Holdings plc ("C4XD", "C4X Discovery" or the "Company") Notice of Results 19 April 2022- C4X Discovery Holdings plc (AIM: C4XD), a pioneering Drug Discovery company, will be announcing its interim results for the six months ended 31 January 2022 on Thursday 28 April 2022
Posted at 03/12/2021 10:36 by bloomberg2
("C4XD", "C4X Discovery" or the "Company")Clive Dix receives the Scrip Lifetime Achievement Award 20213 December 2021 - C4X Discovery Holdings plc (AIM: C4XD), is delighted to announce that its Chief Executive Officer, Dr Clive Dix together with Dame Kate Bingham, the leaders of the UK Vaccine Taskforce, have won the Lifetime Achievement Award at the 2021 Scrip Awards. The Scrip Awards applaud the essential role that the pharmaceutical, biotech and other allied industries play in improving healthcare.Eva-Lotta Allan, Chairman of C4X Discovery, said: "We are very proud of this significant achievement by both Clive and Kate and we are thankful for the incredibly important work that they and the whole of the UK Vaccine Taskforce have carried out. Throughout his impressive career, Clive has contributed significantly to the industry and to us, at C4XD, his drive and determination to best serve patients is what makes Clive the great leader and CEO that he is and everyone at C4XD is delighted to see them all recognised through the Scrip Lifetime Achievement Award."
Posted at 21/11/2021 11:49 by alloa2003
As people have mentioned on numerous occassion - if for example the INDV molecule made it to market, that would cost INDV a potential maximum £219m ($294) in payments (plus royalties on top I believe) to C4XD, then we have the other bigger deal and an even bigger one in the pipeline. C4XD currently has a market value of £100m so INDV taking out C4XD at double the share price would be cost neutral and give them free exposure to the other deal signed and future deals. Its is all starting to hot up, this one could go anywhere
Posted at 18/11/2021 10:49 by 1aconic
The full INDV trial results are (according to INDV) expected to be published by the end of their Q4. By my reckoning that's means before the end of Jan 2022. However, they've already announced that the phase one was promising and have already moved onto phase 2. What we don't however know is what milestone payments are triggered between phase one and phase two. C4XD are in a very healthy cash position at the moment and I don't personally see a scenario where another diluting fund raise would be needed in the next couple of years just for general expenses. However, the market might be prepared to give it a chunky re-rate if there was another healthy injection of cold hard cash from the INDV project milestone or another of the pipeline molecules being licensed. To my mind, that's one option for what's moving the share price currently. Also, C4XD seems currently to be very reasonably valued for an increasingly proven Biotech... you just have to compare it to the likes of Exsciencia for proof of that. All Clive Dix would have to do in the next results is to drop "progress with AI led technologies" into the report and you'd need a re-rate of 10x here to make it comparible to peers.
Posted at 25/8/2020 22:20 by the stigologist
Perfectly normal for Deputy Chair of UK Vaccine Taskforce to speak to Bill Gates Interestingly Bill Gates is one of biggest investors in Schrodinger (SDGR) Mkt Cap $5bn Schrodinger is the nearest equivalent to C4XD IF C4XD share price doesn't go up soon I can see a US Company snapping them up for 100p+ The Indivior deal alone at $294m makes C4XD cheap at 100p (c.£130m Mkt Cap) Clive today told us the NRF2/IL17/a4B7 projects have similar potential
C4x Discovery share price data is direct from the London Stock Exchange
ADVFN Advertorial
Your Recent History
LSE
C4XD
C4x Discov..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20221001 11:48:28